Results 31 to 40 of about 3,050,532 (174)

A case for newborn screening for pyridoxine-dependent epilepsy. [PDF]

open access: yesCold Spring Harb Mol Case Stud, 2022
Pyridoxine dependent epilepsy due to mutations in ALDH7A1 (PDH-ALDH7A1) is a highly treatable developmental and epileptic encephalopathy. Pharmacologic doses of pyridoxine are associated with dramatic clinical seizure improvement and most patient achieve adequate seizure control with pyridoxine alone.
Coughlin CR   +2 more
europepmc   +5 more sources

Phenotypic Variability of Pyridoxine-Dependent Epilepsy

open access: yes, 2019
Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by seizures in neonates or infants, which is unresponsive to antiepileptic drugs but controlled by pyridoxine.
ERÇAL, MURAT DERYA   +2 more
openaire   +2 more sources

Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy. [PDF]

open access: yesNeurology, 2022
BACKGROUND AND OBJECTIVES: Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is a developmental epileptic encephalopathy characterized by seizure improvement after pyridoxine supplementation. Adjunct lysine reduction therapies (LRTs) reduce the accumulation of
Coughlin CR   +23 more
europepmc   +2 more sources

Treatable cause of refractory seizures in an infant with a novel mutation

open access: yesJournal of Pediatric Neurosciences, 2021
Pyridoxine-dependent epilepsy is a treatable cause of epilepsy, which is very well known. It is most commonly caused by mutations in ALDH7A1 and PNPO genes. A 5-month-old infant presented with refractory seizures.
Ruchi R Mittal   +2 more
doaj   +1 more source

Long-term course of early onset developmental and epileptic encephalopathy associated with 2q24.3 microduplication

open access: yesEpilepsy & Behavior Reports, 2022
Copy number variations (CNVs) have been related to developmental and epileptic encephalopathy (DEE). The 2q24.3 region includes a cluster of genes for voltage-gated sodium channels (SCN) and CNVs in this region cause DEE. However, the long-term course of
Takuya Masuda   +8 more
doaj   +1 more source

Feasibility of newborn screening for pyridoxine-dependent epilepsy. [PDF]

open access: yesMol Genet Metab
Pyridoxine-dependent epilepsy (PDE-ALDH7A1) is a developmental epileptic encephalopathy historically characterized by seizures that are resistant to antiseizure medications. Treatment with pyridoxine and lysine reduction therapies are associated with seizure control and improved developmental outcomes. In rare circumstances, patients have died prior to
Pauly K   +9 more
europepmc   +3 more sources

Callosal alterations in pyridoxine‐dependent epilepsy [PDF]

open access: yesDevelopmental Medicine & Child Neurology, 2014
AimWhile there have been isolated reports of callosal morphology differences in pyridoxine‐dependent epilepsy (PDE), a rare autosomal disorder caused by ALDH7A1 gene mutations, no study has systematically evaluated callosal features in a large sample of patients.
Friedman, S.D.   +9 more
openaire   +3 more sources

Epilepsia por dependência de piridoxina: um relato de caso

open access: yesResidência Pediátrica, 2023
Pyridoxine-dependent epilepsy (EDP) is an autosomal recessive disease clinically represented by recurrent seizures. The diagnosis is made by clinical observation, and may be assisted by electroencephalography (EEG) and biochemical and genetic tests.
Larissa Magalhães de Paiva   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy